Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 59

Cited In for PubMed (Select 15175276)

1.

Electronic health records and improved nursing management of chronic obstructive pulmonary disease.

Liu F, Zou Y, Huang Q, Zheng L, Wang W.

Patient Prefer Adherence. 2015 Mar 24;9:495-500. doi: 10.2147/PPA.S76562. eCollection 2015. Erratum in: Patient Prefer Adherence. 2015;9:607.

2.

Association of cytokines in individuals sensitive and insensitive to dust mites in a Brazilian population.

Caniatti MC, Marchioro AA, Guilherme AL, Tsuneto LT.

PLoS One. 2014 Sep 19;9(9):e107921. doi: 10.1371/journal.pone.0107921. eCollection 2014.

3.

Integrative genomics of chronic obstructive pulmonary disease.

Hobbs BD, Hersh CP.

Biochem Biophys Res Commun. 2014 Sep 19;452(2):276-86. doi: 10.1016/j.bbrc.2014.07.086. Epub 2014 Jul 29. Review.

PMID:
25078622
4.

Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis.

Cho MH, McDonald ML, Zhou X, Mattheisen M, Castaldi PJ, Hersh CP, Demeo DL, Sylvia JS, Ziniti J, Laird NM, Lange C, Litonjua AA, Sparrow D, Casaburi R, Barr RG, Regan EA, Make BJ, Hokanson JE, Lutz S, Dudenkov TM, Farzadegan H, Hetmanski JB, Tal-Singer R, Lomas DA, Bakke P, Gulsvik A, Crapo JD, Silverman EK, Beaty TH; NETT Genetics, ICGN, ECLIPSE and COPDGene Investigators.

Lancet Respir Med. 2014 Mar;2(3):214-25. doi: 10.1016/S2213-2600(14)70002-5. Epub 2014 Feb 7.

5.

Genetic determinants of chronic obstructive pulmonary disease in South Indian male smokers.

Arja C, Ravuri RR, Pulamaghatta VN, Surapaneni KM, Raya P, Adimoolam C, Kanala KR.

PLoS One. 2014 Feb 24;9(2):e89957. doi: 10.1371/journal.pone.0089957. eCollection 2014.

6.

Transforming Growth Factor- β 1 Gene Polymorphism (T29C) in Egyptian Patients with Hepatitis B Virus Infection: A Preliminary Study.

Talaat RM, Dondeti MF, El-Shenawy SZ, Khamiss OA.

Hepat Res Treat. 2013;2013:293274. doi: 10.1155/2013/293274. Epub 2013 Dec 18.

7.

Gene polymorphisms and chronic obstructive pulmonary disease.

Wu X, Yuan B, López E, Bai C, Wang X.

J Cell Mol Med. 2014 Jan;18(1):15-26. doi: 10.1111/jcmm.12159. Epub 2013 Nov 21.

8.

Refining susceptibility loci of chronic obstructive pulmonary disease with lung eqtls.

Lamontagne M, Couture C, Postma DS, Timens W, Sin DD, Paré PD, Hogg JC, Nickle D, Laviolette M, Bossé Y.

PLoS One. 2013 Jul 30;8(7):e70220. doi: 10.1371/journal.pone.0070220. Print 2013.

9.

Association of genes of protease-antiprotease balance pathway to lung function and emphysema subtypes.

Kukkonen MK, Tiili E, Vehmas T, Oksa P, Piirilä P, Hirvonen A.

BMC Pulm Med. 2013 Jun 4;13:36. doi: 10.1186/1471-2466-13-36.

10.

Genetic influences on cystic fibrosis lung disease severity.

Weiler CA, Drumm ML.

Front Pharmacol. 2013 Apr 23;4:40. doi: 10.3389/fphar.2013.00040. eCollection 2013.

11.

Genetic association analysis of complex diseases incorporating intermediate phenotype information.

Li Y, Huang J, Amos CI.

PLoS One. 2012;7(10):e46612. doi: 10.1371/journal.pone.0046612. Epub 2012 Oct 19.

12.

Updates on the COPD gene list.

Bossé Y.

Int J Chron Obstruct Pulmon Dis. 2012;7:607-31. doi: 10.2147/COPD.S35294. Epub 2012 Sep 18. Review.

13.

Molecular mechanisms of MMP9 overexpression and its role in emphysema pathogenesis of Smad3-deficient mice.

Xu B, Chen H, Xu W, Zhang W, Buckley S, Zheng SG, Warburton D, Kolb M, Gauldie J, Shi W.

Am J Physiol Lung Cell Mol Physiol. 2012 Jul;303(2):L89-96. doi: 10.1152/ajplung.00060.2012. Epub 2012 May 18.

14.

Coordinated DNA methylation and gene expression changes in smoker alveolar macrophages: specific effects on VEGF receptor 1 expression.

Philibert RA, Sears RA, Powers LS, Nash E, Bair T, Gerke AK, Hassan I, Thomas CP, Gross TJ, Monick MM.

J Leukoc Biol. 2012 Sep;92(3):621-31. doi: 10.1189/jlb.1211632. Epub 2012 Mar 16.

15.

Estimation of TGF-β1 genotypes in Egyptian smokers; association with FEV(1) in COPD patients.

Bohy ME, Ahmed M, Ezzeldin N, Ezzeldin H, Mahmoud M, Shehata A.

Arch Med Sci. 2010 Mar 1;6(1):71-6. doi: 10.5114/aoms.2010.13510. Epub 2010 Mar 9.

16.

Genetic variation and clinical heterogeneity in cystic fibrosis.

Drumm ML, Ziady AG, Davis PB.

Annu Rev Pathol. 2012;7:267-82. doi: 10.1146/annurev-pathol-011811-120900. Epub 2011 Oct 17. Review.

17.

Cytokine biomarkers and chronic pain: association of genes, transcription, and circulating proteins with temporomandibular disorders and widespread palpation tenderness.

Slade GD, Conrad MS, Diatchenko L, Rashid NU, Zhong S, Smith S, Rhodes J, Medvedev A, Makarov S, Maixner W, Nackley AG.

Pain. 2011 Dec;152(12):2802-12. doi: 10.1016/j.pain.2011.09.005. Epub 2011 Oct 14.

18.

Combining disease models to test for gene-environment interaction in nuclear families.

Hoffmann TJ, Vansteelandt S, Lange C, Silverman EK, DeMeo DL, Laird NM.

Biometrics. 2011 Dec;67(4):1260-70. doi: 10.1111/j.1541-0420.2011.01581.x. Epub 2011 Mar 14.

19.

An agent-based model of inflammation and fibrosis following particulate exposure in the lung.

Brown BN, Price IM, Toapanta FR, DeAlmeida DR, Wiley CA, Ross TM, Oury TD, Vodovotz Y.

Math Biosci. 2011 Jun;231(2):186-96. doi: 10.1016/j.mbs.2011.03.005. Epub 2011 Mar 6.

20.

SOX5 is a candidate gene for chronic obstructive pulmonary disease susceptibility and is necessary for lung development.

Hersh CP, Silverman EK, Gascon J, Bhattacharya S, Klanderman BJ, Litonjua AA, Lefebvre V, Sparrow D, Reilly JJ, Anderson WH, Lomas DA, Mariani TJ.

Am J Respir Crit Care Med. 2011 Jun 1;183(11):1482-9. doi: 10.1164/rccm.201010-1751OC. Epub 2011 Feb 17.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk